STEVENSON, Md.--(BUSINESS WIRE)-- Brower Piven, A Professional Corporation, has commenced an investigation of potential securities law violations by Dynavax Technologies Corporation ("Dynavax" or the "Company") (NasdaqCM: DVAX).

Robbins Geller Rudman & Dowd LLP ("Robbins Geller") (http://www.rgrdlaw.com/cases/dynavax/) today announced that a class action has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of ...

The major movers in the sector included Dynavax Technologies Corporation (NASDAQ: DVAX), Warner Chilcott Plc (NASDAQ: WCRX), Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), and Actavis Inc. (NYSE: ACT).

Boston, MA, 06/17/2013 (nysepost) - The share prices of Dynavax Technologies Corporation (NASDAQ:DVAX) had been traded in the price range of $1.13 and $1.25 on Friday.

A lawsuit was filed on behalf of investors in Dynavax Technologies Corporation (NASDAQ:DVAX) shares over alleged securities laws violations.

Boston, MA, 06/14/2013 (nysepost) - The share prices of Dynavax Technologies Corporation (NASDAQ:DVAX) had declined by 13.04 percent to close at $1.20 per share for the end of last trading session on Thursday.

Law Firm Finkelstein Thompson LLP Announces Investigation of Dynavax Technologies Corp. WASHINGTON--(BUSINESS WIRE)-- Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Dynavax Technologies Corp.

Dynavax Technologies Corporation (NASDAQ:DVAX) shares plunged 27.13% to $1.80. The company, on June 10 reported that it recently concluded a meeting with the U.S.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Dynavax Technologies Corp. ("Dynavax" or the "Company") (NASDAQ: DVAX).

Holzer Holzer & Fistel, LLC is investigating whether Dynavax Technologies Corporation ("Dynavax" or the "Company") (NASDAQ: DVAX) and/or certain of its officers complied with the federal securities laws when making statements to investors between July ...